Delivery Order SPE2DE24D0013-SPE2D626F64X4

The Defense Logistics Agency Medical Supply Chain has awarded a $2,024 delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28), a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems and reagents. This firm fixed-price delivery order, designated XPRSTREPA-10, was awarded on December 30, 2025, with an ultimate completion date of January 7, 2026, and carries no set-aside designation. The contract is for performance at Cepheid's Sunnyvale facility and represents a continuation of the company's long-standing role as a primary federal supplier of diagnostic solutions, particularly molecular testing capabilities for infectious diseases including COVID-19, influenza, and other respiratory pathogens.

This delivery order reflects Cepheid's established position as a core supplier across multiple federal healthcare agencies, supported by the company's comprehensive portfolio of GeneXpert diagnostic platforms, molecular testing reagents, and maintenance services. Cepheid maintains significant prime indefinite delivery contracts with the Department of Veterans Affairs, including a $32.8 million single-award contract with VISN 6 extending through September 30, 2030, and a $6.7 million contract with VISN 17 through December 28, 2029. These vehicles, combined with ongoing procurement from the Defense Logistics Agency Medical Supply Chain, Indian Health Service, Defense Health Agency, and U.S. Coast Guard, demonstrate the federal government's reliance on Cepheid's molecular diagnostic capabilities to support clinical laboratory operations and infectious disease testing requirements across the military health system and federal healthcare network.